IFM Investors and UniSuper to acquire a majority stake in PRP Diagnostics.

IFM Investors, an investment services provider, and UniSuper, an Australian superannuation fund, agreed to acquire a majority stake in PRP Diagnostics, a diagnostic imaging provider. Financial terms were not disclosed. “PRP is a leading provider of high quality, advanced diagnostic imaging services and we are delighted to welcome IFM Investors and UniSuper as long-term partners to the business. We have attractive opportunities to grow and expand our business and look forward to working with IFM Investors and UniSuper as majority investors in our company," Paul Richard, PRP Diagnostics CEO.